{
    "Trade/Device Name(s)": [
        "LIAISON\u00ae TSH",
        "LIAISON\u00ae Control Thyroid 1",
        "LIAISON\u00ae Control Thyroid 2",
        "LIAISON\u00ae Control Thyroid 3"
    ],
    "Submitter Information": "DiaSorin Inc.",
    "510(k) Number": "K130469",
    "Predicate Device Reference 510(k) Number(s)": [
        "K961491",
        "K090541"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JLW",
        "JJX"
    ],
    "Summary Letter Date": "April 5, 2013",
    "Summary Letter Received Date": "March 1, 2013",
    "Submission Date": "February 22, 2013",
    "Regulation Number(s)": [
        "21 CFR 862.1690",
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Thyroid stimulating hormone test system",
        "Clinical Chemistry Quality Control Material"
    ],
    "Analyte Class(es)": [
        "endocrine",
        "chemistry"
    ],
    "Analyte(s)": [
        "Thyroid stimulating hormone (TSH)",
        "Thyrotropin",
        "Thyrotropic hormone"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "LIAISON\u00ae XL Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent immunoassay (CLIA)",
        "Sandwich immunoassay"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for DiaSorin LIAISON\u00ae TSH chemiluminescent immunoassay and thyroid control materials for quantitative measurement of thyroid stimulating hormone in serum using the LIAISON\u00ae XL Analyzer.",
    "Indications for Use Summary": "Quantitative determination of thyroid stimulating hormone (TSH) in human serum for diagnosis of thyroid or pituitary disorders; control materials intended to monitor accuracy and precision of the DiaSorin LIAISON\u00ae TSH assay.",
    "fda_folder": "Clinical Chemistry"
}